-
Grant Funds Regenerative Gel for Treating Skin Ulcers
A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers.
-
Infographic – Q3 Digital Health Venture Funds Slide
Venture funding for start-ups worldwide applying digital technologies to health care continued to fall in the third quarter of 2022, both in deals and dollars invested.
-
New Funds Awarded for Rapid Infection Diagnostics
A developer of faster infection diagnostics is receiving another $8.2 million from an international group supporting solutions to antibiotic resistant microbes.
-
Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised
A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…
-
Guide to Entering and Profiting in the World of Investments
By investing in a company, product, or venture, you are essentially betting that the future will be brighter than the present.
-
Trial Shows Wearable Device Can Reduce Migraine
Results from a clinical trial show an electronic device worn on the arm can reduce migraine occurrences in people with history of the condition.
-
Three Tips for Starting as a Freelance Consultant
What does it take to be an effective freelance consultant?
-
Tech Maintenance
Science & Enterprise’s parent company is undergoing a technology upgrade, so we won’t be publishing today.
-
Infographic – US Biotech Venture Funds Fall in Q3
Venture funds for U.S. biotechnology and pharmaceutical start-ups declined in the third quarter of 2022 from the 2021 record pace, but remain on track for historic highs.